Skip to main content
Premium Trial:

Request an Annual Quote

Eurogentec, BD Ink Dx Licensing, Supply Deal

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Eurogentec today announced it has finalized technology transfer and licensing agreements with the BD Diagnostics division of Becton Dickinson.

One deal covers diagnostic manufacturing technology and the other is a multi-year supply agreement. Under the terms of the agreements, Eurogentec will provide BD Diagnostics with diagnostic manufacturing technology and technical assistance. BD expects to use the technology to develop molecular diagnostic kits.

Eurogentec will also provide BD with molecular diagnostic kit components.

Financial terms of the deals were not disclosed.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.